Alberto Diaz, PhD, MBA, is a Strategic Partnering Manager at Debiopharm, where he focuses on external innovation and scientific scouting to identify emerging therapeutic assets, technologies and potential partnering opportunities. His work involves monitoring scientific and industry developments, identifying innovative approaches to address unmet medical needs, and building relationships with biotech companies and academic institutions, with a particular interest in oncology.

He holds a PhD in Life Sciences from the University of Heidelberg, where he conducted his doctoral research at the German Cancer Research Center (DKFZ), specializing in cancer biology, and an MBA. His background combines multidisciplinary biomedical research with business strategy, bridging scientific innovation and pharmaceutical development.